Sneaker Fortress on MSN4mon
The PUMA Inhale Returns: A Blast from the Past or Just a Tired Rehash?The PUMA Inhale sneaker belongs to the Cellerator family, which features the brand’s signature CELL cushioning technology.
Company forecast currency-adjusted sales below last year's level Management flags weak U.S. market, announces 500 job cuts Puma shares down 23% Sign up here. Chief Executive Arne Freundt said Puma ...
Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer.
Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer. In February 2024, Puma initiated ALISCA™-Lung1, a Phase II clinical ...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation ...
Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer. In February 2024, Puma initiated ALISCA™-Lung1, a Phase II clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback